Review
Open access
Aug 2026
A Review of the Current Literature Regarding Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Preserved Ejection Fraction and Timing of Initiating Therapy
Although evidence supporting SGLT2i use in HFpEF continues to strengthen, uncertainty remains regarding the optimal timing of therapy initiation, and a literature review aims to explore the current literature regarding SGLT2i, as well as the optimal time to initiate therapy.
M. Sahyouni, Chirag Lodha, Vivek Joseph Varughese
· Cureus · 0 citations